ADIAL PHARMACEUTICALS, INC.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
Insider trades, last 90 days
3 buys · 0 sells
- Bought $106.33K
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
17
- +2 vs. Q1 2026
- Total value $334.56K
Superinvestors holding ADIL
0
- None of the superinvestors held ADIL at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by ADIL insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 20265:08 PM ET | Jul 14 – Jul 16, 2026 | Coastlands Capital LP10% Owner | PPurchaseCommon Stock | +3.23K | $2.6881 | +$8.69K | 388.31K | +0.8% | SEC |
| Jul 13, 202610:30 AM ET | Jul 9 – Jul 10, 2026 | Coastlands Capital LP10% Owner | PPurchaseCommon Stock | +11.75K | $2.777 | +$32.64K | 385.08K | +3.1% | SEC |
| Jul 1, 202610:30 AM ET | Jun 29, 2026 | Coastlands Capital LP10% Owner | PPurchaseCommon Stock | +25K | $2.60 | +$65K | 373.32K | +7.2% | SEC |
| Jun 16, 2026 | Jun 12, 2026 | Young Wendy B.Director | PPurchaseCommon Stock · Derivative | +36.38K | $2.75 | +$100.04K | 36.38K | – | SEC |
| Oct 3, 2023 | Sep 29, 2023 | Schuyler KevinDirector | PPurchaseCommon Stock | +700 | $2.74 | +$1.92K | 700 | New position | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in ADIL at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 32,119 | $82.23K | 0.00% | +32,119 | New |
| CITADEL ADVISORS LLC | 29,547 | $75.64K | 0.00% | +29,547 | New |
| UBS Group AG | 19,147 | $49.02K | 0.00% | +18,605+3,432.7% | Added |
| StoneX Group Inc. | 19,699 | $35.67K | 0.00% | +19,699 | New |
| GEODE CAPITAL MANAGEMENT, LLC | 12,393 | $31.73K | 0.00% | −11,856−48.9% | Reduced |